These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 18666246)
1. Statins in liver disease: a molehill, an iceberg, or neither? Argo CK; Loria P; Caldwell SH; Lonardo A Hepatology; 2008 Aug; 48(2):662-9. PubMed ID: 18666246 [TBL] [Abstract][Full Text] [Related]
2. Safety of statin therapy in patients with preexisting liver disease. Onofrei MD; Butler KL; Fuke DC; Miller HB Pharmacotherapy; 2008 Apr; 28(4):522-9. PubMed ID: 18363535 [TBL] [Abstract][Full Text] [Related]
3. [Statins in chronic liver diseases: safety and effect]. Li GM; Fan JG Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):478-80. PubMed ID: 20587326 [No Abstract] [Full Text] [Related]
4. 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy. Tzefos M; Olin JL J Clin Lipidol; 2011; 5(6):450-9. PubMed ID: 22108148 [TBL] [Abstract][Full Text] [Related]
5. Use of statins in patients with chronic hepatitis C. Andrus MR; East J South Med J; 2010 Oct; 103(10):1018-22; quiz 1023. PubMed ID: 20818300 [TBL] [Abstract][Full Text] [Related]
17. Statins and hepatitis C virus infection: an old therapy with new scope. Rzouq F; Alahdab F; Olyaee M Am J Med Sci; 2014 Nov; 348(5):426-30. PubMed ID: 24805786 [TBL] [Abstract][Full Text] [Related]
19. Influence of statins on MHC class I expression. Singh P; Kohr D; Kaps M; Blaes F Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224 [TBL] [Abstract][Full Text] [Related]